🔗 Share this article

The top legal official in Texas Ken Paxton is suing the manufacturers of Tylenol, alleging the corporations concealed safety concerns that the medication posed to children's brain development.

The court filing arrives thirty days after Donald Trump publicized an unverified association between taking acetaminophen - also known as acetaminophen - throughout gestation and autism in offspring.

The attorney general is taking legal action against the pharmaceutical giant, which previously sold the drug, the sole analgesic approved for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he stated they "misled consumers by making money from suffering and marketing drugs without regard for the risks."

The company states there is no credible evidence tying acetaminophen to autism.

"These manufacturers misled for generations, knowingly endangering millions to line their pockets," Paxton, a Republican, said.

Kenvue stated officially that it was "deeply concerned by the spread of false claims on the safety of paracetamol and the likely effects that could have on the well-being of US mothers and children."

On its online platform, Kenvue also mentioned it had "consistently assessed the relevant science and there is insufficient valid information that indicates a proven link between consuming paracetamol and autism spectrum disorder."

Groups acting on behalf of physicians and medical practitioners concur.

ACOG has declared acetaminophen - the primary component in Tylenol - is one of the few options for women during pregnancy to manage discomfort and elevated temperature, which can create major wellness concerns if not addressed.

"In more than two decades of research on the consumption of paracetamol in pregnancy, no reliable research has successfully concluded that the usage of paracetamol in any trimester of gestation leads to neurodevelopmental disorders in offspring," the organization said.

This legal action references recent announcements from the Trump administration in claiming the drug is allegedly unsafe.

Recently, the former president generated worry from medical authorities when he told women during pregnancy to "resist strongly" not to consume acetaminophen when ill.

The FDA then published an announcement that doctors should consider limiting the consumption of acetaminophen, while also mentioning that "a proven link" between the medication and autism spectrum disorder in minors has not been proven.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had promised in spring to undertake "comprehensive study program" that would establish the origin of autism spectrum disorder in a limited time.

But specialists cautioned that discovering a unique factor of autism - considered by experts to be the consequence of a complex mix of genetic and external influences - would not be simple.

Autism is a type of permanent neurological difference and impairment that affects how individuals encounter and interact with the world, and is recognized using physician assessments.

In his lawsuit, Paxton - a Trump ally who is campaigning for US Senate - claims the manufacturer and J&J "willfully ignored and attempted to silence the evidence" around acetaminophen and autism spectrum disorder.

This legal action aims to force the firms "remove any commercial messaging" that asserts Tylenol is secure for expectant mothers.

The court case mirrors the concerns of a assembly of mothers and fathers of minors with autism and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in two years ago.

Judicial authorities dismissed the case, saying studies from the family's specialists was inconclusive.